| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 33 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 33 |
| 2 | TACROLIMUS OINTMENT 0.1% | 33 |
| 3 | METHOTREXATE SODIUM | 31 |
| 4 | METHOTREXATE | 28 |
| 5 | PREDNISONE | 28 |
| 6 | RITUXIMAB | 26 |
| 7 | VANCOMYCIN | 25 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 25 |
| 9 | ASPIRIN | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CROVALIMAB | 21 | 0.1736 |
| 1 | DANICOPAN | 4 | 0.0129 |
| 2 | SODIUM HYALURONATE | 4 | 0.0049 |
| 3 | BODY CLEANSER | 3 | 0.0042 |
| 4 | PERPHENAZINE | 7 | 0.0034 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 25 | 0.0030 |
| 6 | NAFCILLIN SODIUM | 2 | 0.0022 |
| 7 | DEXCHLORPHENIRAMINE MALEATE | 2 | 0.0020 |
| 8 | SKIN PROTECTANT | 4 | 0.0015 |
| 9 | REMIFENTANIL HYDROCHLORIDE | 3 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 77 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 51 |
| 2 | Platinum-based Drug [EPC] | 36 |
| 3 | Proton Pump Inhibitor [EPC] | 33 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 31 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 29 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 29 |
| 7 | Glycopeptide Antibacterial [EPC] | 25 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 24 |
| 9 | Anti-IgE [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 21 | 0.1736 |
| 1 | Complement Factor D Inhibitor [EPC] | 4 | 0.0129 |
| 2 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 3 | Human Immunoglobulin G [EPC] | 23 | 0.0011 |
| 4 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 6 | 0.0007 |
| 6 | Antimycobacterial [EPC] | 13 | 0.0005 |
| 7 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 8 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 9 | Glycopeptide Antibacterial [EPC] | 25 | 0.0004 |